References | Surgery n (%) | Chemotherapy n (%) | Beam-delivery | Median total dose (Gy RBE) | Fractions (n) | Dose/fraction GyRBE |
---|---|---|---|---|---|---|
Ladra et al. [13] | NR | 54 (100%) 18 (31.6%)c; 18 (31.5%)f; 16 (28.1%)e; 3 (5.3%)h; 2 (3.5%)d | Passive scanning | 50.4 (36.0–50.4) | NR | NR |
Indelicato et al. [14] | NR | 30 (100%)e/h | Passive scanning | 45 | 25 | 1.8 |
Ludmir et al. [15] | 1 (2.2%) | 46 (100%) 21 (45.7%)f; 10 (21.7%)e; 7 (15.2%)o; 5 (10.9%)h; 3 (6.5%)g | Passive scanning Active scanning | 50.4 (36.0–50.8) | 28 | 1.8–2.0 |
Bradley et al. [16] | 1 (4.2%) | 24 (100%) 15 (62.5%)h; 8 (33.3%)f; 1 (4.2%)i | Passive scanning | 50.4 (41.4–59.4) | 28 | 1.8 |
Indelicato et al. [17] | 14 (45.2%) | 31 (100%) 19 (61.3%)a; 12 (38.7%)b | Passive scanning | 50.4 (36.0–59.4) | 28 | 1.8 |
Buszek et al. [18] | 60 (63.8%) | 94 (100%) 51 (31.6%)f; 15 (31.5%)e; 10 (28.1%)g; 9 (5.3%)a; 6 (3.5%)0; 3 (3.5%)c | Passive scanning Active scanning | 50.4 (36.0–50.8) | 28 | 1.8–2.0 |
Parekh et al. [19] | 20 (54.1%) | 37 (100%) 18 (48.7%)a; 17 (45.9%)b; 2 (5.4%)o | Passive scanning | 50.4 (36.0–55.8) | 28 | 1.8 |
Mizumoto et al. [20] | 41 (74.5%) | 53 (96.4%)NR | NR | 50.4 (36.0–60.0) | NR | NR |
Suzuki et al. [21] | 21 (43.8%) | 46 (95.8%) 40 (83.3%)j; 6 (12.5%)k | NR | 50.4 (41.4–59.4) | NR | NR |
Leiser et al. [22] | 55 (66.3%) | 83 (100%) 59 (71.1%)l; 14 (16.9%)a; 5 (6.0%)m; 3 (3.6%)f; 1 (1.2%)c; 1 (1.2%)n | Active scanning | 54 (41.4–64.8) | 30 | 1.8–2.0 |
Weber et al. [23] | NR | 39 (100%) 28 (71.8%)l; 5 (12.8%)a; 3 (7.7%)b; 3 (7.7%)m | Active scanning | 54 (50.4–55.8) | 30 | 1.8–2.0 |